PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer

Inclusion Criteria: * Breast cancer scheduled for neoadjuvant chemotherapy followed by surgery Exclusion criteria: * Indicated chemotherapy without that a curative tumorectomies is foreseen(planned) * Patient presenting an evolutionary infectious or inflammatory pathology, including an inflammatory breast cancer, being able to be source(spring) of false-positive results(profits) in TEP-FDG * Patient in the course of radiotherapy or of chemotherapy or operated at the level of the thorax in 4 weeks preceding the date foreseen(planned) by the examination TEP (pose(installation) of implantable room(chamber) excludes) * Diabetic waits * Patient already includes in the other protocols of search(research) for Nuclear Medicine or for imaging using ionization radiations * Patient not having given her lit(enlightened) assent * Wait among which the surveillance TEP or the MRI during the chemotherapy will be impossible (that is by geographical or professional imperative, or if contraindication in the MRI, ex: port(bearing) of a pacemaker, cochlear magnetic implants, metal foreign bodies cf protocol) * Of less than 18 years old or pregnant patient. * Breast cancer stage(stadium) IV * Biopsy on the already realized mammary tumor, for the period(delay) lower than 15 j. * In case of alcoholic poisoning or of antecedents of reaction to the injection of ethanol: not inclusion to be discussed.